Cases & Deals

Jefferies and Barclays complete $231 million public offering of Common Stock by AMAG Pharmaceuticals

Clients Jefferies LLC and Barclays Capital Inc.

Jones Day advised Jefferies LLC and Barclays Capital Inc., as representatives of the underwriters, in connection with the $231 million public offering of Common Stock by AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.